Identification of pathology-specific regulators of m 6 A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine

ConclusionThis study provided the first view of the pathology-specific regulators of m6A RNA modification in lung cancers and identified the three-m6A-regulator signature (KIAA1429, METTL3, and IGF2BP1) as an independent prognostic model to classify lung cancers into high- and low-risk groups for patient stratification, prognostic assessment, and personalized treatment toward PPPM in lung cancers.
Source: EPMA Journal - Category: International Medicine & Public Health Source Type: research